Comparison
Omega-3 (DHA/EPA) vs Pterostilbene
Omega-3 (DHA/EPA)
Essential fatty acids critical for brain structure and function. DHA comprises ~40% of brain polyunsaturated fatty acids.
Pterostilbene
Methylated analog of resveratrol with much higher bioavailability. Found in blueberries.
| Field | Omega-3 (DHA/EPA) | Pterostilbene |
|---|---|---|
| Category | neuroprotective | neuroprotective |
| Dose range | 1000–3000mg | 50–250mg |
| Half-life | 24h | — |
| Onset | — | — |
| Evidence | EVIDENCEA | EVIDENCEB |
| Safety | ●●●●● | ●●●●● |
| Legal (US) | USOTC | USOTC |
| PubMed refs | 5200 | 280 |
The comparison in plain English
Auto-generated from dataOmega-3 (DHA/EPA) and Pterostilbene are both in the neuroprotective category respectively. Omega-3 (DHA/EPA) Essential fatty acids critical for brain structure and function. Pterostilbene Methylated analog of resveratrol with much higher bioavailability.
Bottom line
Omega-3 (DHA/EPA) (evidence A, safety 5/5) has a weaker evidence base than Pterostilbene (evidence B, safety 5/5). Omega-3 (DHA/EPA) has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.
Choose Omega-3 (DHA/EPA) if
Omega-3 (DHA/EPA) is the better fit when your goal aligns with its mechanism (DHA (docosahexaenoic acid) is a structural component of neuronal cell membranes, maintaining fluidity and supporting receptor function) and the dose range (1000–3000mg) suits your protocol. Half-life is 24h.
Choose Pterostilbene if
Pterostilbene is the better fit when your goal aligns with its mechanism (Pterostilbene is structurally similar to resveratrol but with two methyl groups attached, increasing lipophilicity and substantially improving blood-brain-barrier penetration (4x oral bioavailability and a longer half-life vs resveratrol)) and the dose range (50–250mg) suits your protocol. Half-life is —h.